NEWSROOM

Kali-Extracts

KALY Announces Anchor Investor In Cannabis Biopharmaceutical Technology At $50 Million Valuation

  Dallas, TX – December 17, 2019  -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) (“KALY”) today announced an anchor investor in its biopharmaceutical technology.  KALY recently announced restructuring its cannabis biopharmaceutical business as part of a strategy to facilitate a strategic investment at a $50 million valuation.  KALY has a U.S. Patented Cannabis Extraction Process and is developing treatments for various medical conditions (see below).  After...

read more

KALY – Kali-Extracts Expects 2020 Revenue Growth Acceleration From CBD Infused Consumer Products

  Dallas, TX – December 11, 2019  -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) (“KALY”) today announced expected revenue growth acceleration in 2020 from the sales of CBD infused consumer products.  The company currently generates revenue from the sale of CBD infused candies and beverages.  KALY produces and sells Hemp4mula chewing gum and gummies available on www.USMJ.com and it has licensed its patented cannabis extraction process for the production of CBD...

read more

KALY – Kali-Extracts Announces Cannabis Biopharmaceutical Business Restructuring

  Dallas, TX – December 10, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) (“KALY”) today announced the company is restructuring its cannabis biopharmaceutical business.  KALY has a U.S. Patented Cannabis Extraction Process and is developing treatments for various medical conditions (see below).  KALY has recently announced receiving two inquiries into the acquisition of the company’s cannabis biopharmaceutical technology valuing the technology at $50...

read more

KALY – Kali-Extracts Proceeds With Capital Infusion Plan At $50 Million Valuation

  Dallas, TX – December 6, 2019  -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) (“KALY”) today announced it will proceed with a capital infusion plan to accelerate the growth of its cannabis biopharmaceutical technology.  KALY has recently announced receiving two inquiries into the acquisition of the company’s cannabis biopharmaceutical technology valuing the technology at $50 million.  KALY has a U.S. Patented Cannabis Extraction Process and is developing...

read more

PURA and KALY Announce Landing First Kenyan Coffee Shipment Adding To $8 Million 2020 Beverage Revenue Target

    Dallas, TX – December 3, 2019 -- – Puration, Inc. (OTC: PURA) today announced the company has landed its first Kenyan coffee shipment.  The company recently announced it will begin producing CBD infused Fair Trade coffee from Kenya.  Now that the first shipment from Kenya has arrived, the company can begin formulating the CBD infusion.  PURA has engaged Kali-Extracts, Inc. (OTC: KALY) to design the CBD infusion for ground coffee.  KALY has a U.S. Patented Cannabis Extraction Process.  PURA...

read more

KALY – Kali-Extracts Anticipates Reaching $1 Million In 2019 Revenue With Q4 Hemp Extraction Contribution

        Dallas, TX – November 29, 2019 -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced that it anticipates reaching $1 million in revenue by year end 2019 with the contribution of its first hemp extraction contracts being realized in the fourth quarter of 2019.  Earlier this week, the company published a financial performance update in conjunction with KALY’s financial performance report through September 30, 2019. KALY’s current revenues come...

read more

KALY – Kali-Extracts Could Reach $1 Million In Total 2019 Revenue

    Dallas, TX – November 27, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed that it has the potential to reach $1 million in revenue by year end 2019.  The company yesterday published a financial performance update in conjunction with KALY’s financial performance report through September 30, 2019. KALY’s current revenues come primarily from the sale of CBD infused products that have utilized KALY’s U.S. Patented Cannabis Extraction...

read more

KALY – Kali-Extracts Financial Performance Update Tomorrow November 26, 2019

  Dallas, TX – November 25, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a management financial performance update scheduled for release tomorrow, November 26, 2019.  The update will be published in conjunction with KALY’s financial performance report through September 30, 2019.  Management will highlight the company’s growing sales and underlying asset value.  Management intends to specifically highlight the company’s potential to...

read more

KALY – Kali-Extracts Confirms Cannabis Biopharmaceutical Capital Infusion Plans

  Dallas, TX – November 21, 2019 – -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed introducing a third option to compete with the two acquisition offers currently being entertained by KALY management.  KALY has recently announced receiving two inquiries into the acquisition of the company’s cannabis biopharmaceutical technology valuing the technology at $50 million.  KALY management is entertaining the inquiries but indicates that the $50...

read more

KALY – Kali-Extracts Introduces Third Option To Compete With Two $50 Million Acquisition Offers

  Dallas, TX – November 20, 2019  -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced introducing a third option to compete with the two acquisition offers currently being entertained by KALY management.  KALY has recently announced receiving two inquiries into the acquisition of the company’s cannabis biopharmaceutical technology valuing the technology at $50 million.  KALY management is entertaining the inquiries but indicates that the $50...

read more

KALY – Kali-Extracts Cannabis Biopharma Asset Could Be Undervalued In Light Of GW Pharma $3.5 Billion Market Cap

      Dallas, TX – November 14, 2019  -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today highlighted GW Pharmaceuticals $3.5 Billion market capitalization.  GW Pharma’s cannabis biopharmaceutical technology is featured today in a ZACHS Investment Research article. KALY has a U.S. Patented Cannabis Extraction Process and is developing treatments for various medical conditions (see below).  Doctors working with KALY on the treatment developments have...

read more

KALY – Kali-Extracts Confirms Second Bid On Its Cannabis Biopharmaceutical Technology Valued At $50 Million

      Dallas, TX – November 12, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed a second party has approached the company to express interest in acquiring KALY’s U.S. Patented Cannabis Extraction Process and related biopharmaceutical technology valued at $50 million.  KALY recently announced entering into discussions with a first investor to explore a possible sale of KALY’s cannabis biopharmaceutical technology.  The first investor...

read more

KALY – Kali-Extracts Announces Second Bidder On Its Cannabis Biopharmaceutical Technology Valued At $50 Million

  Dallas, TX – November 8, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a second party has approached the company to express interest in acquiring KALY’s U.S. Patented Cannabis Extraction Process and related biopharmaceutical technology has valued the technology at $50 million.  KALY recently announced entering into discussions with a first investor to explore a possible sale of KALY’s cannabis biopharmaceutical technology.  The...

read more

KALY – Kali-Extracts Encounters Second Wave Of CBD Extraction Contract Opportunities (USOTC: KALY)

        Dallas, TX – November 6, 2019 -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced that the company’s CBD extraction offering is beginning to see a second wave of contract opportunities.  KALY has so far announced three CBD extraction agreements with hemp farming operations worth a potential $15 million.  Under the agreements, KALY consigns the crop and harvests the hemp in addition to executing the comprehensive CBD extraction process.  As...

read more

KALY – Kali Extracts Previews USDA Organic CBD Products (USOTC: KALY)

  Dallas, TX – November 5, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced plans to introduce USDA Organic CBD Oil and USDA Organic CBD infused beverages early next year in 2020.  KALY recently announced a USDA Organic Certification for its first harvested hemp crop.  Using KALY’s U.S. Patented Cannabis Extraction Process, KALY is now processing CBD oil from the USDA Organic Certified hemp crop.  With the CBD oil from the USDA Organic...

read more

KALY – Kali-Extracts Confirms $50 Million Valuation Of Its Cannabis Biopharmaceutical Technology

  Dallas, TX – November 1, 2019  -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed an investor interested in acquiring KALY’s U.S. Patented Cannabis Extraction Process and related biopharmaceutical technology has valued the technology at $50 million.  Yesterday KALY announced taking a next step with the investor to explore a possible sale.  KALY management has asked the investor to provide a “working” term-sheet for discussion purposes.  The...

read more

KALY – Kali-Extracts Explores $50 Million Cannabis Biopharmaceutical Technology Sale

  Dallas, TX – October 31, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced taking a next step with the investor that has recently valued KALY’s biopharmaceutical technology at $50 Million.  The valuation has been presented to KALY by an investor interested in acquiring KALY’s U.S. Patented Cannabis Extraction Process and associated biopharmaceutical research and developments.  KALY management has asked the investor to provide a...

read more

KALY – Kali-Extracts Entertains $50 Million Cannabis Biopharmaceutical Technology Acquisition Valuation

  Dallas, TX – October 30, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a $50 Million valuation for its cannabis extract biopharmaceutical technology.  The valuation has been presented to KALY by an investor interested in acquiring KALY’s U.S. Patented Cannabis Extraction Process and associated biopharmaceutical research and developments.  KALY management has entered discussions with the investor but not formally expressed at this...

read more

KALY – Kali Extracts Announces USDA Organic Certification For First Hemp Crop

Dallas, TX – October 30, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a USDA Organic Certification for its first crop hemp crop.  KALY has a U.S. Patent for Cannabis Extraction and provides hemp cultivators with harvesting and extraction services.  KALY has signed harvesting and extraction contracts so far worth approximately $15 million.  The first hemp harvest and extraction contract now under way in the State of New York has just...

read more

KALY- Kali-Extracts Announces Third CBD Extraction Agreement Adding To $15 Million In Current Contracts

      Dallas, TX – October 30, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a new CBD extraction agreement adding to the company’s previously announced extraction contracts with hemp farming operations worth a potential total of $15 million.  This is a third consignment agreement whereby the hemp farming operation consigns its crop to KALY for harvesting and extraction and KALY, after processing the harvested hemp, markets the end...

read more

PURA – Puration To Present THC Beverage Rollout Thursday This Week October 31st

  Dallas, TX – October 28, 2019 (GLOBE NEWSWIRE)  -- via – Puration, Inc. (USOTC: PURA) today announced the company will rollout plans for its THC Savor beverage in Canada this Thursday, October 31, 2019.  With Canada legalizing cannabis infused beverages this month, PURA is moving forward with its already designed THC Savor beverage.  Utilizing its sole license of Kali-Extracts’ (USOTC: KALY) U.S. Patented Cannabis Extraction Process, PURA has designed a THC infused beverage named THC Savor....

read more

KALY – Kali-Extracts To Review Acquisition Interest In Its Cannabis Extract Biopharmaceutical Technology This Wednesday, October 30, 2019

Dallas, TX – October 28, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced plans to issue an update this Wednesday, October 30th, 2019 regarding the recent acquisition interest in KALY’s Cannabis Extract Biopharmaceutical Technology.  KALY CEO Frederick Ferri commented on the acquisition interest in KALY’s Cannabis Extract Biopharmaceutical Technology indicating that the interest stems from industry investors recognizing that KALY’s...

read more

KALY – Kali Extracts CEO Explores Hemp Expansion Industry In North Carolina

    Dallas, TX – October 25, 2019  -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced CEO Frederick Ferri met with Butterball’s Jim Maxwell and North Carolina 7th District Congressman David Rouzer to discuss the expansion of the hemp industry in North Carolina. Utilizing KALY’s U.S. Patented Cannabis Extraction Process, KALY has signed direct cannabis extraction contracts with hemp farming operations with a total value so far of $15 million. ...

read more

KALY – Kali-Extracts Announces New CBD Hemp4mula Gummies Now Available On USMJ.com

  Dallas, TX – October 23, 2019  -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced its new CBD Hemp4mula Gummies are now available to order on www.usmj.com.   www.usmj.com/Hemp4mula-Gummies   Hemp4mula Gum is also available from USMJ’s eCommerce site at www.usmj.com/Hemp4mula-gum.   In the fourth quarter of last year, 2018, KALY acquired NCMB.  NCMB owns and operates a US Patented Cannabis Extraction Process.  In NCMB’s four years of...

read more

KALY – Kali-Extracts Confirms Acquisition Interest In Its Cannabis Extract Biopharmaceutical Technology

    Dallas, TX – October 24, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed a recent conditional acquisition proposal from an investor interested in the acquisition of KALY’s Cannabis Extract Biopharmaceutical Technology.  KALY CEO Frederick Ferri commented yesterday on the acquisition interest in KALY’s Cannabis Extract Biopharmaceutical Technology indicating that the interest stems from industry investors recognizing that KALY’s...

read more

KALY – Kali-Extracts Announces Getting Courted For Potential Sale Of Cannabis Extract Biopharmaceutical Technology

    Dallas, TX – October 23, 2019  -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced the company has recently received serious interest from an investor exploring the acquisition of KALY’s Cannabis Extract Biopharmaceutical Technology.  KALY CEO Frederick Ferri commented on the acquisition interest in KALY’s Cannabis Extract Biopharmaceutical Technology indicating that the interest stems from industry investors recognizing that KALY’s...

read more

KALY – Kali-Extracts Publishes Photos From Historic First Legal Hemp Harvest

Dallas, TX – October 17, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today published photos on the company’s website from its first historic hemp harvest since the Federal legalization of hemp cultivation in the United States.  KALY has already begun harvesting its first hemp crop in the state of New York signed under a consignment contract worth a potential $5 million.  KALY has hired a photo journalist to record the event.     View More Hemp...

read more

KALY – Kali-Extracts Reports Increased Interest In Patented Cannabis Extraction Process In Reaction To Cannabis 2.0

  Dallas, TX – October 15, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced recent interest from Canadian cannabis sector businesses in reaction to Cannabis 2.0.  Later this week, on October 17, 2019, cannabis infused edibles, beverages, extracts and topicals become legal for sale in Canada.  KALY owns and operates a U.S. Patented Cannabis Extraction Process used currently for the production of beverages and candies.  KALY’s primary...

read more

KALY – Kali-Extracts Hemp Harvest And CBD Extraction In Full Swing

    Dallas, TX – October 14, 2019 -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced engaging a photo journalist to record the company’s first historic hemp harvest since the Federal legalization of hemp cultivation in the United States.  KALY has already begun harvesting its first hemp crop in the state of New York signed under a consignment contract worth a potential $5 million.  The first photos taken by the photo journalist are expected to be...

read more

KALY – Kali-Extracts Is Making CBD Infused Coffee

Dallas, TX – October 11, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced today announced that as part of the sole license it has granted to Puration, Inc. (USOTC: PURA) for use of the KALY U.S. Patented Cannabis Extraction Process for the production of beverages, KALY has recently been engaged by PURA to design a coffee infusion process. Earlier today, PURA announced the company will begin producing CBD infused Fair Trade coffee from...

read more

Categories

Mcap MediaWire - Costumer Service

Translate »